Aier Eye Hospital Group Future Growth
Future criteria checks 2/6
Aier Eye Hospital Group is forecast to grow earnings and revenue by 17.8% and 15.4% per annum respectively. EPS is expected to grow by 17.8% per annum. Return on equity is forecast to be 19.7% in 3 years.
Key information
17.8%
Earnings growth rate
17.8%
EPS growth rate
Healthcare earnings growth | 21.2% |
Revenue growth rate | 15.4% |
Future return on equity | 19.7% |
Analyst coverage | Good |
Last updated | 30 Jul 2024 |
Recent future growth updates
Recent updates
Aier Eye Hospital Group (SZSE:300015) Has A Rock Solid Balance Sheet
Jul 28Shareholders Are Optimistic That Aier Eye Hospital Group (SZSE:300015) Will Multiply In Value
Jul 12Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Business Is Yet to Catch Up With Its Share Price
Jun 05Statutory Profit Doesn't Reflect How Good Aier Eye Hospital Group's (SZSE:300015) Earnings Are
May 02Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Fell Short of Analyst Expectations: Here's What You Need To Know
Apr 28Calculating The Intrinsic Value Of Aier Eye Hospital Group Co., Ltd. (SZSE:300015)
Apr 02Many Would Be Envious Of Aier Eye Hospital Group's (SZSE:300015) Excellent Returns On Capital
Mar 15Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Shares May Have Run Too Fast Too Soon
Feb 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 31,408 | 5,675 | 5,878 | 7,664 | 16 |
12/31/2025 | 27,251 | 4,827 | 4,892 | 6,956 | 19 |
12/31/2024 | 23,249 | 4,015 | 5,042 | 6,202 | 18 |
3/31/2024 | 20,543 | 3,477 | 3,862 | 5,510 | N/A |
12/31/2023 | 20,367 | 3,359 | 4,412 | 5,872 | N/A |
9/30/2023 | 19,106 | 3,348 | 4,446 | 6,063 | N/A |
6/30/2023 | 18,254 | 2,945 | 4,139 | 5,544 | N/A |
3/31/2023 | 16,962 | 2,695 | 3,764 | 5,110 | N/A |
1/1/2023 | 16,110 | 2,524 | 3,102 | 4,491 | N/A |
9/30/2022 | 16,456 | 2,677 | 3,426 | 4,840 | N/A |
6/30/2022 | 15,760 | 2,499 | 3,067 | 4,488 | N/A |
3/31/2022 | 15,658 | 2,450 | 2,869 | 4,376 | N/A |
1/1/2022 | 15,001 | 2,323 | 2,590 | 4,084 | N/A |
9/30/2021 | 14,943 | 2,181 | 2,666 | 4,037 | N/A |
6/30/2021 | 15,096 | 2,163 | 3,263 | 4,586 | N/A |
3/31/2021 | 13,782 | 2,128 | 3,017 | 4,095 | N/A |
12/31/2020 | 11,912 | 1,724 | 2,450 | 3,344 | N/A |
9/30/2020 | 10,824 | 1,694 | 2,122 | 2,778 | N/A |
6/30/2020 | 9,405 | 1,360 | 1,112 | 1,751 | N/A |
3/31/2020 | 9,387 | 1,160 | 983 | 1,637 | N/A |
12/31/2019 | 9,990 | 1,379 | 1,333 | 2,078 | N/A |
9/30/2019 | 9,616 | 1,345 | 1,218 | 2,022 | N/A |
6/30/2019 | 8,978 | 1,195 | 903 | 1,619 | N/A |
3/31/2019 | 8,506 | 1,091 | 692 | 1,536 | N/A |
12/31/2018 | 8,009 | 1,009 | 589 | 1,400 | N/A |
9/30/2018 | 7,705 | 1,005 | 825 | 1,802 | N/A |
6/30/2018 | 7,153 | 890 | 751 | 1,690 | N/A |
3/31/2018 | 6,512 | 803 | 755 | 1,466 | N/A |
12/31/2017 | 5,963 | 743 | N/A | 1,330 | N/A |
9/30/2017 | 5,300 | 721 | N/A | 992 | N/A |
6/30/2017 | 4,671 | 646 | N/A | 873 | N/A |
3/31/2017 | 4,283 | 594 | N/A | 798 | N/A |
12/31/2016 | 4,000 | 557 | N/A | 775 | N/A |
9/30/2016 | 3,807 | 538 | N/A | 624 | N/A |
6/30/2016 | 3,631 | 499 | N/A | 630 | N/A |
3/31/2016 | 3,429 | 459 | N/A | 537 | N/A |
12/31/2015 | 3,166 | 428 | N/A | 522 | N/A |
9/30/2015 | 3,006 | 413 | N/A | 479 | N/A |
6/30/2015 | 2,740 | 367 | N/A | 480 | N/A |
3/31/2015 | 2,535 | 331 | N/A | 484 | N/A |
12/31/2014 | 2,402 | 309 | N/A | 454 | N/A |
9/30/2014 | 2,316 | 296 | N/A | 486 | N/A |
6/30/2014 | 2,200 | 266 | N/A | 428 | N/A |
3/31/2014 | 2,091 | 240 | N/A | 438 | N/A |
12/31/2013 | 1,985 | 223 | N/A | 413 | N/A |
9/30/2013 | 1,928 | 217 | N/A | 421 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300015's forecast earnings growth (17.8% per year) is above the savings rate (2.9%).
Earnings vs Market: 300015's earnings (17.8% per year) are forecast to grow slower than the CN market (21.9% per year).
High Growth Earnings: 300015's earnings are forecast to grow, but not significantly.
Revenue vs Market: 300015's revenue (15.4% per year) is forecast to grow faster than the CN market (13.4% per year).
High Growth Revenue: 300015's revenue (15.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300015's Return on Equity is forecast to be low in 3 years time (19.7%).